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Abstract
Background: Colonization of the body is an important step in Staphylococcus aureus infection. S. aureus colonizes
skin and mucous membranes in humans and several animal species. One important ecological niche of S. aureus is
the anterior nares. More than 60% of the S. aureus in the nose are found in vestibulum nasi. Our aim was to
describe the localization of S. aureus in nasal tissue from healthy carriers.
Methods: Punch skin biopsies were taken from vestibulum nasi from healthy volunteers (S. aureus carriers and
non−/intermittent carriers, n = 39) attending the population-based Tromsø 6 study. The tissue samples were
processed as frozen sections before immunostaining with a specific S. aureus antibody, and finally evaluated by a confocal
laser-scanning microscope.
Results: Our results suggest that S. aureus colonize both the upper and lower layers of the epidermis within the nasal
epithelium of healthy individuals. The number of S. aureus in epidermis was surprisingly low. Intracellular localization of
S. aureus in nasal tissue from healthy individuals was also detected.
Conclusions: Knowledge of the exact localization of S. aureus in nasal tissue is important for the understanding of the
host responses against S. aureus. Our results may have consequences for the eradication strategy of S. aureus in carriers,
and further work can provide us with tools for targeted prevention of S. aureus colonisation and infection.
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Background
The nose is an important site for Staphylococcus aureus
and methicillin-resistant S. aureus (MRSA) colonization
in humans, and S. aureus is predominantly located in
the anterior nasal vestibule on the septum adjacent to
the nasal ostium on the moist squamous epithelium
[1, 2]. In this location, S. aureus can exist as a commensal
without any signs or symptoms of an infection. The preva-
lence of persistent nasal carriage with S. aureus is 20–30%
in adult human populations [3, 4], and most often it is an
endogenous S. aureus strain that causes infection [5–7].
Prevention and elimination of the carrier state may
contribute in reducing the S. aureus disease burden [4].
Successful nasal decolonization of S. aureus is difficult to
achieve, and S. aureus readily recolonizes the nose, the
throat and other sites within one week, commonly with
the same S. aureus genotype [8–11]. Today, nasal mupiro-
cin is the most efficacious regimen of S. aureus eradication
from the anterior nares [12, 13]. However, the success rate
for eradication of MRSA is low 12 months after
decolonization [14].
The anterior part of the nasal cavity (vestibulum nasi)
is lined with stratified, keratinized, squamous epithelium.
More than 60% of S. aureus in the nasal vestibule are
found here [1]. It has also been shown that S. aureus can
bind to the ciliated nasal epithelial cells in the inner part
of the nasal cavity (internal nares) with pseudostratified
columnar ciliated epithelium [15–18]. The skin in vesti-
bulum nasi consists of two main layers: epidermis and
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dermis [19]. Epidermis consists of five strata called the
stratum corneum, stratum lucidum, stratum granulo-
sum, stratum spinosum, and stratum basale [20, 21].
The five main strata are characterized by cells at varying
stages of development. Stratum corneum, also called the
cornified layer, is the outermost layer and contains ma-
ture keratinocytes called corneocytes [21, 22]. The
stratum lucidum is a thin, translucent layer with no nu-
clei. Stratum granulosum are flattened keratinocytes
which contain cytoplasmic granula and secretory organ-
elles [21, 23]. Stratum spinosum consists of several
layers of large polygonal keratinocytes, also called spin-
ous keratinocytes. Stratum basale is the layer that
separates dermis from epidermis, and it consists of un-
differentiated epidermal cells. The cells in this layer are
responsible for constant renewal of cells in epidermis
[21]. Dermis is a layer of connective tissue and contains
accessory epidermal structures, lymphatic and vascular
conduits, nerves and nerve endings, collagen and elastic fi-
bers, in addition to many specialized immune cells [20, 21].
Successful adhesion of microbes to the human host
depends on an efficient combination of microbial surface
components as well as human host ligands. S. aureus ad-
hesion to human epithelium is mediated by wall teichoic
acid (WTA) and microbial surface components recogniz-
ing adhesive matrix molecules (MSCRAMMs) [24, 25].
WTA is important for both initial and late phases of S.
aureus colonization, while surface proteins are import-
ant for long term S. aureus persistence in the nasal
cavity [25]. Clumping factor B (ClfB) [26, 27] and the
iron-regulated surface determinant A (IsdA) [26, 28] are
important for nasal colonization and adhere to cytokeratin
and loricrin/involucrin in corneocytes [26, 27, 29, 30]. S.
aureus adhesion is also dependent on the host phenotype
[25, 31, 32], but very few ligands in the host are known.
Recently, it was shown that the interaction between the
serine-aspartate repeat protein D (SdrD) and the human
desmosome protein, desmoglein 1, is important for adhe-
sion to keratinocytes in vitro [33].
S. aureus not only adhere to cell surfaces during
colonization, but also invade both phagocytic and non-
phagocytic cells where they can survive antibiotic treat-
ment [16, 34, 35]. Here, they constitute a significant risk
factor for recurrent episodes of disease, e.g. rhinosinusi-
tis [15, 16], tonsillitis [36] and osteomyelitis [37].
For developing new strategies to eradicate S. aureus and
diminish the risk of invasive disease, it is crucial to under-
stand the host-pathogen interaction in colonization, inva-
sion and infection. Fundamental questions of these
aspects include; where in the epithelial layer is S. aureus
located and how does S. aureus interact with cells in the
nasal vestibule in healthy individuals? Thus, our aim was
to determine where S. aureus localize in the nasal epithe-
lium, and to evaluate a possible intracellular residency.
Methods
Study design and population
In 2010 an invitation letter for participation in the study
was sent to a random selection of men and women age
40–42 years (n = 193) with known S. aureus nasal car-
rier status in the sixth Tromsø study (Tromsø 6) from
October 2007–August 2008, a large population-based
multipurpose health study [38, 39]. The S. aureus carrier
status of the participants included in this study was de-
fined in Tromsø 6 [38, 39]. Our working definition for
nasal carriage types was according to van Belkum et al.
[4]. There are two types of human nasal S. aureus car-
riers: persistent carriers and others, i.e. noncarriers and
intermittent carriers are grouped together. A total of 48
individuals (25% of the invited) were willing to partici-
pate in this cross-sectional sub-study in 2010–2011.
Among these volunteers, we performed a selection based
on S. aureus carriage results from Tromsø 6 with the
purpose of recruiting approximately 50% carriers of S.
aureus and 50% non−/intermittent carriers, with an
equal distribution of women and men. The selection
represents a homogenous population according to age,
with small age-related tissue-changes. The S. aureus
noncarriers were considered as normal controls. Before
tissue sampling, the volunteers were interviewed by a
physician concerning known allergies, medicinal use,
and ongoing cold/upper respiratory infection or fever.
Exclusion criteria included known allergies against local
anesthetics, and current use of anticoagulants (warfarin,
acetylsalicylic acid) or other medication that preclude
tissue sampling. If the subject was undergoing antibiotic
treatment, symptomatic respiratory infection or fever at
the time of sampling, the donor was asked to return for
sampling after resolution of symptoms. Thirty-nine
(n = 39) volunteers were finally included for nasal biopsy
sampling at the University Hospital of North Norway
(UNN HF), i.e. 18 females and 21 males, 18 S. aureus
carriers and 21 non- /intermittent carriers.
Ethics statement
This work was performed in compliance with the ethical
guidelines established by UiT- The Arctic University of
Norway. Each participant gave written informed consent
prior to the tissue sampling. Subject recruitment, enroll-
ment and sampling of nasal tissue samples have been ap-
proved by the Regional Committee for Medical and
Health Research Ethics, Rec North, Norway (Document
reference 2010/146–7).
Microbiological sampling for detection and spa-typing of
S. aureus
After interviewing the participants, a microbiological
swab sample was taken from one nostril for confirm-
ation of S. aureus carriage according to procedures
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described earlier [39]. S. aureus isolates and MRSA were
identified using standard bacteriological criteria and
laboratory methods, and all S. aureus isolates were spa-
typed according to Sangvik et al. [39].
Tissue collection
A tissue sample was harvested from one nostril, while a
microbiological sample was harvested from the other
nostril. Selection of nostril (left or right side) for 3 mm
punch biopsy sampling was done randomly by flipping a
coin. Before tissue sampling, local anesthetic was
injected (Xylocaine 1% infiltration anesthetic, 0.4 mm
diameter hypodermic needle, approx. 1 ml) subcutane-
ously at the sampling site. Entry of injection cannula was
at least 5 mm from sampling site. The thickness of the
histological specimen was 2–4 mm. It included the
whole of epidermis and parts of dermis. The biopsy was
harvested from the transition zone between skin and
mucosa in the upper lateral vestibulum nasi. In total, 33
samples were obtained from keratinized squamous epi-
thelium without nasal hair and six samples from the
same region containing nasal hair. The biopsy sampling
was divided between two physicians.
Embedding of tissue and sectioning of frozen sections
Immediately after tissue sampling the tissue was embed-
ded in Frozen Section Medium (OCT) (Fisher Scientific/
Thermo Scientific), frozen in precooled liquid isopen-
tane, and stored at −80 °C. The frozen tissue was sec-
tioned in 10 μm sections with a glass/cryostat knife. The
biopsy was sectioned vertically from the dermal site to-
wards the epidermis with a cryostat blade that was
cleaned with alcohol after obtaining each section. We
started sectioning from one side of the biopsy towards
the middle of the biopsy where most of our sections
were obtained. Sections were placed on Super Frost Plus
glass slides (Thermo Scientific) for immunohistochemis-
try and ordinary glasses for Hematoxylin-Eosin (HE)-
staining. Sections and remaining tissue were stored at
−80 °C for further use.
Fluorescence labeling/staining
To detect S. aureus, 10 μm cryostat sections of nasal tis-
sue were fixed (4% Formaldehyde), blocked (2% Goat
serum, Sigma-Aldrich; 0.1% cold Fish Skin Gelatin; 1%
bovine serum albumin, Sigma-Aldrich; 0.1% Triton X-
100; 0.05% Tween-20; diluted in 1X phosphate buffered
saline PBS, ThermoFisher Scientific), and incubated with
rabbit polyclonal S. aureus antibody (ab20920, Abcam)
1:5000 dilution over night at 4 °C followed by Alexa
Fluor 546® goat anti-rabbit IgG (A-11010, Molecular
Probes™, Thermo Fisher Scientific) 1:1000 dilution label-
ing, or Alexa Fluor 488® goat anti-rabbit IgG (A-11008,
Molecular Probes™, Thermo Fisher Scientific) 1:1000
dilution labeling for 30–60 min. The slides were incu-
bated with DRAQ5 1:1000 (BioStatus) to stain keratino-
cyte nuclei, and Alexa Fluor 594 Phalloidin (A12381,
Molecular Probes™, Thermo Fisher Scientific) 1:40 dilu-
tion for staining actin red. The samples were dried and
the glass slides mounted by adding Prolong Gold
Antifade reagent with DAPI (P36935, Molecular
Probes™, Thermo Fisher Scientific). Samples were stored
at +4 °C before immediate microscopy.
Tissue analysis/microscopic analysis
Slides were analyzed by confocal microscopy using a
Zeiss confocal microscope LSM510 Meta (Carl Zeiss
Microscopy GmbH, Germany), with ×63 or ×40 objec-
tives. Images were captured using the LSM510-imaging
software system, version 4.2.0.121 (Carl Zeiss Inc.). For
determining intracellular localization we used the Zeiss
confocal microscope LSM510 Meta (Carl Zeiss Micros-
copy GmbH, Germany) using the LSM510 imaging soft-
ware or Leica TCS SP5 (Leica Microsystems CMS
GmbH, Germany) using the LAS AF software, version
2.3.0. For inspection of intracellular residency, multiple
consecutive images were taken in the axial z-axis of tis-
sue samples with a slice thickness of 0.2 μm or 0.5 μm.
The tissue sections were assessed for evidence of S.
aureus, visualized as bright green coccoid structures
fluorescing on stimulation with a 488-nm laser. Samples
were categorized as intracellular positive if S. aureus
could be identified in at least one z-plane and closely lo-
calized adjacent to intraepithelial nuclei.
The relative amount of S. aureus present in the nasal
tissue was calculated by randomly selecting minimum 10
consecutive tissue sections from 14 donors (eight car-
riers and six non−/intermittent carriers randomly
selected), labeling the sections with S. aureus specific
antibody, performing confocal laser scanning microscopy
(CLSM) and calculating the mean number of S. aureus
per tissue section. We counted all positive green cocci.
Microscope images/slides were read and analyzed by
two independent, blinded observers (RSO and AMH) for
the presence of S. aureus in epidermis and intracellular
localization.
Hematoxylin-eosin (HE) staining
We fixed 10 μm tissue sections in 4% formaldehyde
and immersed with hematoxylin (Harris, Thermo Sci-
entific), stained in Scott’s solution (NaHCO3, MgSO4,
and H2O), and immersed in eosin (Thermo Scientific).
The sections were dehydrated in 96% ethanol and
100% ethanol, immersed in xylene (Sigma-Aldrich),
and finally mounted onto glass slides with Histokit
(Fisher Scientific) before examination in light micro-
scope. The HE stained sections were used to investi-
gate histopathological alterations.
Hanssen et al. BMC Microbiology  (2017) 17:89 Page 3 of 11
Gram-staining
For identification of Gram-positive cocci, frozen sections
were stained following standard Gram-staining proce-
dures (Sigma Aldrich). The Gram-stained sections were
examined by light microscopy.
Bacterial controls and antibody specificity
To avoid cross-reaction with Staphylococcus epidermidis
and to test the specificity of the S. aureus polyclonal
antibody we included bacterial controls in the immuno-
fluorescence staining. We used S. aureus ATCC 25923
as positive control for primary antibody binding, and S.
epidermidis ATCC 12228 as negative control. Overnight
cultures of the controls were made in 5 ml Brain-Heart
Infusion broth. 1 ml o.n. culture was centrifuged for
10 min at 3000 rpm, the supernatant was removed and
the pellet resuspended in 1 ml 1× PBS. Centrifugation
was repeated for 10 min at 3000 rpm, the pellet was re-
suspended in 1 ml 1× PBS, and 1 μl suspension was
spotted on a glass slide, before flame fixation. From this
point, the positive and negative controls were prepared
in exactly the same way as the frozen tissue sections.
Green fluorescence was detected from the positive
controls only.
Determination of S. aureus colony forming units (CFU) in
the nose of healthy volunteers
To estimate the likelihood of detecting S. aureus in nasal
tissue biopsies from healthy individuals, we performed a
pilot study where 14 volunteers (colleagues working at
the Department for Medical Biology, UiT – The Arctic
University of Norway) were sampled by nasal swabbing
according to Sangvik et al. 2011 [39], and the S. aureus
CFU in the nose was determined. One nostril of each
volunteer was swabbed in the anterior region, 1–1.5 cm
inside the nostril. The swab was resuspended thoroughly
in 1 ml of 0.9% sodium chloride. Twenty microliters
from each tenfold dilution (100–108) was applied onto
blood agar plates and ChromID S. aureus agar (Bio-
merieux) and incubated at 37 °C for 24 h. Colonies
were counted in spots from two dilutions (3 if pos-
sible). The CFU/nostril was calculated, both total
CFU and S. aureus CFU.
Results
S. aureus Carrier status versus results from confocal
microscopic analyses and nasal swabbing
Thirty-nine healthy volunteers were included in the
study, and their carrier status was determined in the pre-
vious Tromsø 6 study, i.e. 18 carriers and 21 non−/inter-
mittent carriers. According to one swab sampling in this
study, 16 out of 39 individuals were positive for S. aur-
eus (Table 1), while 23 out of 39 individuals were nega-
tive for S. aureus. No MRSA were detected. S. aureus
was observed in biopsy sections by CLSM in ten out of
18 persistent carriers (Table 1). Among the 21 non−/inter-
mittent carriers, we found S. aureus in three of the biop-
sies by CLSM (Table 1). Thus, detection of S. aureus by
one nasal swabbing and CLSM showed some inconsist-
ency, i.e. three individuals that were negative for S. aureus
by swabbing, both in the Tromsø 6 study and in the
present study, were positive for S. aureus by CLSM,
whereas three individuals with positive swab cultures in
both studies, were negative for S. aureus by CLSM (Table
1). Two individuals defined as non−/intermittent carriers
in the Tromsø 6 study, were positive for S. aureus by one
swabbing, but negative by CLSM in our study (Table 1).
Four individuals that were defined as persistent S. aureus
carriers in the Tromsø 6 study were negative for S. aureus
in our study based on swabbing and CLSM analysis (Table
1). Seven out of 39 biopsies were not examined in our
study due to damaged sections, which was most likely
caused by tissue sampling errors or sectioning errors
(Table 1, not determined).
Fourteen different spa-types were found among the
S. aureus isolates from the 39 healthy participants in
this study (Additional file 1: Table S1). Twelve spa-
types were found in one individual each, while t084
and t246 were found in two individuals each. Six in-
dividuals had changed spa-types since the Tromsø 6
study (Additional file 1: Table S1).
Estimation of S. aureus in nasal vestibule in healthy
individuals
We performed a pilot study to estimate the likelihood of
detecting S. aureus in biopsies. From nasal swabbing of
14 healthy colleagues, we found between 0 and 1.5 × 104
S. aureus CFU/nostril (Table 2). By a rough estimate,
this should correspond to approximately 0–200 S. aur-
eus per biopsy surface area.
Biopsies were then obtained from the 39 participants
and HE staining and CLSM/immunohistochemistry
(IHC) were performed. The cryo-sectioning of nasal tis-
sue showed all layers of epidermis, confirming the qual-
ity of the biopsies (Fig. 1).
Localization of S. aureus in epidermis and in nasal secretions
We detected S. aureus in both the upper and lower
layers of epidermis by CLSM/IHC (Figs. 2, 3, 4, 5 and 6).
S. aureus was most often found in stratum corneum
(Fig. 2). We also found S. aureus in stratum spinosum
(Figs. 3, 4 and 5), as far down as in stratum basale
(Figs. 5 and 6), and on the border to dermis (Fig. 6b).
Nasal secretion was observed in sections from both
carriers and non−/intermittent carriers, and S. aureus
was often observed in association with nasal secretion
in pairs or clusters (Fig. 2b). S. aureus was often observed
as single bacterial cells (Fig. 2a and c, Figs. 3, 4, 5 and 6)
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or in pairs (Fig. 2b and d) in the epidermal layers. Gram-
staining confirmed the presence of Gram-positive cocci in
the epidermis of both carriers and non−/intermittent car-
riers (results not shown).
Intracellular localization of S. aureus was assessed by
CLSM/IHC (Fig. 7) using specific antibodies to S. aureus
and staining of different structures (nucleus and actin).
Three-dimensional reconstruction of highly magnified z-
stacks was possible using CLSM. Consecutive z-plane
images (Z-scan) showed fluorescent S. aureus (green) in
close proximity/closely localized to the cellular nuclei of
epithelial cells (blue) (Fig. 7).
Among the 39 biopsy donors, we selected 14 donors
randomly for calculating the number of S. aureus per tis-
sue section by CLSM/IHC. The counting was performed
by blinding the sample numbers and the examiner was
unaware whether a carrier or non−/intermittent carrier
was examined when performing the confocal micros-
copy. On average, there were 0.61 S. aureus per tissue
section among all the 14 selected individuals in our
study. Of note, S. aureus was detected in sections from
three of the six selected non−/intermittent carriers,
while no S. aureus was detected in the blinded sections
from three out of eight S. aureus carriers.
Discussion
In the present study, we have assessed the S. aureus
localization within vestibulum nasi in healthy individ-
uals. By using a confocal scanning laser microscopy
approach, we found that S. aureus is localised in both
the upper and lower layers of epidermis within the
nasal epithelium of healthy individuals. We also ob-
served intracellular localization of S. aureus in the
different layers of epidermis.
Table 1 Results from nasal swab culture and confocal laser scanning microscopy (CLSM) of tissue sections
S. aureus carriage status in the
Tromsø 6 studya (n = 39)
Presence of S. aureus by one nasal
swab sampling present studyc (n = 39)
Presence of S. aureus by CLSM present
studyd (n = 39)
Persistent carriers (n = 18) + 14 + 10
− 3
nd 1
− 4 + 0
− 4
nd 0
Othersb (n = 21) + 2 + 0
− 2
nd 0
− 19 + 3
− 10
nd 6
aResults from nasal swabbing (two samplings with median time interval of 28 days) and spa-typing in the Tromsø 6 study in October 2007–August 2008. S. aureus carriage
status as defined by van Belkum et al. [4]
bIncludes both noncarriers and intermittent carriers
cResults from one nasal swab sampling and spa-typing in the present study in 2010–2011; +, positive for S. aureus; −, negative for S. aureus
dConfocal laser scanning microscopy (CLSM); +, positive for S. aureus; −, negative for S. aureus; nd, not determined, CLSM not performed
Table 2 Number of S. aureus found in nares of healthy individuals
Number of S. aureus CFU/nostril (n = 14)a
n = 8 n = 2 n = 1 n = 1 n = 1 n = 1
0 50 1.5 × 102 5.0 × 102 6.0 × 102 1.5 × 104
aResults from a pilot study where we determined S. aureus CFU/nostril in 14
healthy colleagues from Department of Medical Biology by one nasal swab culture
Fig. 1 Representative histological view of epidermis in an S. aureus
nasal carrier. Nasal secretion and four stratified cell layers in epidermis are
marked. Sections were stained with hematoxylin-eosin, and examined in
light microscope
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Fig. 2 Localization of S. aureus in the upper part of epidermis. Inset represents a zoomed portion of the image. Scale bar is in micrometers. We
used a confocal laser scanning microscopy (CLSM) ×63 objective. a-b S. aureus is localized on the border between stratum corneum and stratum
granulosum. Green fluorescence labeling of S. aureus, blue fluorescence labeling of keratinocyte cell nuclei and S. aureus DNA. Primary antibody
rabbit polyclonal antibody to S. aureus (ab20920, Abcam), secondary antibody Alexa Fluor 488® goat anti-rabbit IgG (Molecular Probe™, Thermo
Fisher Scientific), and DRAQ5 (BioStatus). c S. aureus in stratum corneum. The same labeling is used as in a-b, but in addition, we used Alexa Fluor
594 Phalloidin (A12381, Molecular Probes™, Thermo Fisher Scientific) staining actin red. d Combined CLSM and light microscopy of nasal tissue
section. S. aureus seen as red cocci in pairs, presumably on the border between stratum corneum and stratum granulosum. Primary S. aureus
rabbit polyclonal antibody (ab20920, Abcam) and a secondary antibody Alexa Fluor 546 goat anti-rabbit IgG (Molecular Probes™, Thermo Fisher
Scientific) were used
Fig. 3 Localization of S. aureus in stratum spinosum by CLSM. Inset represents a zoomed portion of the image. Scale bar is in micrometers. We
used a CLSM ×63 objective. The sections are oriented so that the outermost epidermis layer is shown in the upper left corner. a-b Green fluorescence
labeling of S. aureus, blue fluorescence labeling of keratinocyte cell nuclei and S. aureus DNA. c Same labeling as in a and b, but in addition we used
red fluorescence labeling of actin. Primary antibody rabbit polyclonal antibody to S. aureus (ab20920, Abcam), secondary antibody Alexa Fluor 488®
goat anti-rabbit IgG (Molecular Probe™, Thermo Fisher Scientific), Alexa Fluor 594 Phalloidin (Molecular Probes™, Thermo Fisher Scientific)
and DRAQ5 (BioStatus)
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Fig. 4 Confocal laser scanning microscopy of frozen section of nasal tissue from an S. aureus carrier. Overview (a-b) and detailed/zoomed portion
of image (c-d) showing S. aureus in stratum spinosum. Scale bar is in micrometers. Green fluorescence labeling of S. aureus, blue fluorescence
labeling of keratinocyte cell nuclei and S. aureus DNA, red fluorescence labeling of actin. Primary antibody rabbit polyclonal antibody to S. aureus
(ab20920, Abcam), secondary antibody Alexa Fluor 488® goat anti-rabbit IgG (Molecular Probe™, Thermo Fisher Scientific), Alexa Fluor 594 Phalloidin
(Molecular Probes™, Thermo Fisher Scientific) and DRAQ5 (BioStatus). We used a CLSM ×63 objective
Fig. 5 Localization of S. aureus on the border between stratum spinosum and stratum basale. Overview (a) and detailed image (b) of nasal tissue
from an S. aureus carrier by confocal laser scanning microscopy. Scale bar is in micrometers. White brace indicates the region which is magnified
in (b). Green fluorescence labeling of S. aureus, blue fluorescence labeling of keratinocyte cell nuclei and S. aureus DNA. Primary antibody rabbit
polyclonal antibody to S. aureus (ab20920, Abcam), secondary antibody Alexa Fluor 488® goat anti-rabbit IgG (Molecular Probe™, Thermo Fisher
Scientific), and DRAQ5 (BioStatus). We used a CLSM ×63 objective
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As expected, we identified the majority of S. aureus in
the stratum corneum. In artificially colonized cotton
rats, localization of S. aureus has been shown in the
stratum corneum of intranasal squamous epithelium
[24] where S. aureus appeared as single cells or diplo-
cocci, a finding that is corroborated by our study. This is
also in accordance with other studies showing that ad-
herence of S. aureus to nasal cells is directly related with
the age of the epithelial cells. The most differentiated
cells bind most S. aureus, while the youngest cells (less
differentiated keratinocytes in the lower epidermis layer)
bind fewer S. aureus [40]. Identical findings have been
shown for S. epidermidis [41].
A histological study revealed S. aureus in the stratified
squamous epithelium and in hair follicles in vestibulum
nasi post mortem [42]. The study suggested that there is
a difference between persistent and intermittent S. aur-
eus carriers concerning niche localization, and difficul-
ties in decolonization might be related to S. aureus
confined to hair follicles and subsequent re-colonization.
We took samples from regions with nasal hair in only
six donors, but unfortunately we did not observe hair
follicles in any of these samples.
The number of S. aureus captured from swabbing
of the nasal vestibule is quite low [1], but the number
of S. aureus in the nostrils is in accordance with
other studies [1, 26, 43]. As expected, the low density
of S. aureus was confirmed by the microscopic ana-
lyses. Normally, there are higher bacterial densities in
diseased tissue compared with tissue from healthy
carriers [16]. A previous study using confocal micros-
copy on tissue sections from rhinosinusitis patients,
found that approximately 1/3 of S. aureus infected
cells (regardless of cell type) carried more than 10
bacteria [16]. We confirmed our IHC/fluorescence
staining protocol by using a skin tissue section from
a patient with confirmed S. aureus skin infection as
positive control (results not shown). In this positive
control, we observed large clusters of S. aureus in
both upper and lower layers of epidermis. Our
findings show a clear difference between S. aureus
colonization in healthy and inflamed vestibular skin,
as the density of S. aureus was low in the healthy
volunteers in our study.
The squames (stratum corneum) is constantly being
shed from the skin surface, and shedding contributes
to the clearing of attached bacteria [44]. This might
explain why we saw only a few S. aureus in the nasal
tissue sections. In many of our tissue sections, the
stratum corneum was detached from the epithelial
layer, and was visible as loose appendages in the
proximity of the epithelium.
Fig. 6 Localization of S. aureus in the lower part of epidermis by CLSM. Overview and detailed image/zoomed portion of the image showing (a)
S. aureus on the border between stratum spinosum and stratum basale, and (b) S. aureus on the border between the stratum basale and dermis.
Inset represents a zoomed portion of the image. Scale bar is in micrometers. Green fluorescence labeling of S. aureus, blue fluorescence labeling
of keratinocyte cell nuclei and S. aureus DNA. Primary antibody rabbit polyclonal antibody to S. aureus (ab20920, Abcam), secondary antibody Alexa
Fluor 488® goat anti-rabbit IgG (Molecular Probe™, Thermo Fisher Scientific), and DRAQ5 (BioStatus). We used a CLSM ×63 objective
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One important deviation in our study when defining
colonization status, is that when we screen for S. aur-
eus, we normally swab both nostrils [45], but in this
study we only swabbed one of the nostrils and har-
vested our histologic sample from the other nostril.
The reason for this was that we wanted to keep an
intact skin structure and not alter the skin surface be-
fore biopsy sampling. It has previously been shown
that carriers are more likely to carry S. aureus in one
nostril than in both nostrils [46], and this could per-
haps explain the cases where we detected S. aureus
by swab culture, but not by CLSM of biopsied nasal
tissue from the same individual, or vice versa.
We observed a switch of S. aureus colonization status
in the period between the Tromsø 6 study and our study
in some of the participants. Three individuals defined as
non−/intermittent carriers in the Tromsø 6 study, were
negative for S. aureus by nasal swab sampling and posi-
tive for S. aureus by CLSM of nasal epithelium in the
present study. We also observed the opposite, i.e. four
individuals defined as S. aureus carriers in the Tromsø 6
study were S. aureus negative in our study by both swab-
bing and CLSM. A change in colonization status of some
individuals was expected [39]. Another expected obser-
vation was that some persistent carriers exhibited
different spa types in the two studies. These observa-
tions are in line with earlier reports [39, 47], and could
be examples of strain replacement or co-colonization.
Intracellular persistence of S. aureus in connection
with infection, e.g. recurrent sinusitis, has been shown
in previous studies [15, 16]. We confirmed intracellular
S. aureus localization in the stratum spinosum in healthy
individuals by CLSM images at multiple z-planes within
the nasal tissue by using specific antibodies. We did not
perform a systematic investigation of intracellular
localization and it was only performed in a few randomly
selected donors. S. aureus can live as a commensal
within humans without causing overt disease, and there
is considerable evidence of intracellular localization of S.
aureus [16, 34, 35] in neutrophils [48], osteoblasts [49],
nasal epithelial cells [16, 50], and endothelial cells [51].
However, we did not expect to find intracellular S.
aureus in nasal tissue from healthy individuals.
The intracellular localization of S. aureus has been
suggested to provide a sanctuary for the bacteria, pro-
tecting them from the innate host defense system, and
perhaps also from antimicrobial agents [16], hence serv-
ing as a reservoir for chronic or relapsing infection.
Some of the participants in our study were negative by
S. aureus nasal swabbing, but positive for S. aureus by
CLSM indicating that intracellular localization of S. aureus
could be difficult to detect by nasal swabbing. A possible
explanation for the discrepancy could be intracellular
localization or it could be due to a single nostril S. aureus
carrier status.
Our work shows that S. aureus is primarily observed
in the debris overlying the nasal epithelium, whereas sin-
gle staphylococci can also be observed in deeper intrae-
pithelial layers. We observed nasal secretions in most of
the tissue samples from both carriers and non−/inter-
mittent carriers. Clusters of S. aureus were very often lo-
calized within the nasal secretions in carriers, and
especially in two of our donors. One could hypothesize
that staphylococci are in a dormant state in their intrae-
pithelial localization. In the healthy nasal vestibule, the
stratum corneum is not surveilled by the dendritic cells
[52], which could mean that staphylococci might remain
undetected by the body’s immune system. In addition,
nasal crust formation could be considered a natural
growth medium for staphylococci, leading to colony for-
mation under the right host conditions.
Conclusions
Our results suggest that S. aureus colonize both the
upper and lower layers of the epidermis within the nasal
epithelium of healthy individuals. The number of S.
aureus in epidermis was surprisingly low. Intracellular
localization of S. aureus in nasal tissue from healthy in-
dividuals was also detected. The intracellular state may
Fig. 7 Intracellular localization of S. aureus in nasal epithelial cells. S.
aureus is labeled with primary rabbit polyclonal antibody to S. aureus
(Abcam), secondary antibody Alexa Fluor 488 goat anti-rabbit IgG
(green) (Molecular Probes™, Thermo Fisher Scientific), DRAQ5 (BioStatus)
for keratinocyte nuclei (blue) and Alexa Fluor 594 Phalloidin (A12381,
Molecular Probes™; Thermo Fisher Scientific) for actin (red). Confocal laser
scanning microscopy of frozen sections. Projection is constructed from
confocal Z-stacks (0,2 um thick), 63× objective. Image to the left and on
top corresponds to a vertical view in the z-plane. Z-plane images reveal a
single cellular nucleus (blue) closely related to fluorescing S. aureus (green)
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protect the bacteria from traditional decolonization pro-
cedures and cause problems with re-colonization. Thus,
decolonization strategies targeting intracellular S. aureus
should be considered for future testing. Much is still un-
known about S. aureus persistence in nasal tissue.
Knowledge of the exact localization of S. aureus in nasal
tissue will be important for the understanding of the
host responses against S. aureus. Further work on the
identification of bacterial and host factors can provide
us with tools for targeted prevention of S. aureus colon-
isation and infection.
Additional file
Additional file 1: Table S1. Results from spa-typing in the previous
Tromsø 6 study and the present study. Additional documentation. (PDF 91 kb)
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